🕵️ Neuphoria Therapeutics Inc. ($NEUP)
SEC insider & ownership activity, last 12 months · CIK 1191070 · every row links its SEC filing
Insider buy value was withheld pending verification over the last 12 months. One red-flag 8-K in the window: Delisting notice (3.01), Dec 18, 2025.
Insider flow
1 buyer, value withheld pending verification (1 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| LYNX1 Capital Management LP | 1 | value withheld pending verification | 0 | – | Oct 21, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Weston Nichols | 37.1% | 13D | Oct 21, 2025 | filing ↗ | |
| Weston Nichols | 16.3% | 13D | Dec 26, 2025 | filing ↗ | |
| LYNX1 Capital Management LP | 16.3% | 13D | Dec 26, 2025 | filing ↗ | |
| SHAY Capital LLC | 7.3% | 13G | Oct 31, 2025 | filing ↗ | |
| SHAY Capital Holdings LLC | 7.3% | 13G | Oct 31, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jul 20, 2026 | filing ↗ |
| Change of control (5.01) | Jul 20, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 20, 2026 | filing ↗ |
| Other events (8.01) | May 21, 2026 | filing ↗ |
| Material agreement (1.01) | Dec 31, 2025 | filing ↗ |
| Agreement terminated (1.02) | Dec 31, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 31, 2025 | filing ↗ |
| Delisting notice (3.01) | Dec 18, 2025 | filing ↗ |
| Shareholder vote (5.07) | Dec 12, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 27, 2025 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Oct 27, 2025 | filing ↗ |
| Charter/bylaw changes (5.03) | Oct 27, 2025 | filing ↗ |
| Other events (8.01) | Oct 27, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 27, 2025 | filing ↗ |
| Other events (8.01) | Oct 20, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 20, 2025 | filing ↗ |